A photo of Rebecca Brady.

Director, Adult Clinical Services

Associate Professor, UC Department of Pediatrics

513-636-4578

513-636-7655

Board Certified

Best Doctors logo

My Biography & Research

Biography

I was inspired to go to college by my parents, who were children of the Great Depression and did not have the financial resources to attend college themselves. In medical school and residency, my mentor physicians encouraged me to choose infectious diseases as a subspecialty.

As an infectious disease physician and director of Adult Clinical Services, I treat each patient as I would want to be treated. Infectious Disease is a small division, so we work closely with our nurses and medical assistants to provide timely and exceptional patient care.

I received the Centers for Disease Control and Prevention Immunization Champion Award for the state of Ohio in 2018. This award was for my efforts in improving immunization rates among Ohio’s children.

In my research, my colleagues and I are looking for ways to improve vaccines for influenza. We are also studying candidate vaccines for SARS-CoV-2, which is the cause of COVID-19 disease.

During my spare time, I enjoy embroidery, and I make my own clothes.

Clinical Interests

Adult and pediatric infectious disease

Research Interests

Cytomegalovirus and other viral infections 

Academic Affiliation

Associate Professor, UC Department of Pediatrics

Divisions

Infectious Diseases, Infectious Diseases

My Locations

My Education

MD: University of Kentucky, Lexington, KY, 1988.

Residency: Internal Medicine/Pediatrics, University of Louisville, Louisville, KY.

Fellowships: Pediatric Infectious Diseases, Children's Hospital Medical Center, Cincinnati, Ohio; Adult Infectious Diseases, University of Cincinnati, Cincinnati, OH.

Certifications: Pediatrics, 1992, recertified 1999; Internal Medicine, 1993; Pediatric Infectious Diseases, 1997; Adult Infectious Diseases, 1997.

My Publications

Bacterial meningitis: Fever, headache and a Stiff Neck...Looking pretty sick. Huang, FS; Brady, RC; Mortensen, J. Introduction to Clinical Infectious Diseases: A Problem-Based Approach. : Springer International Publishing; Springer International Publishing; 2019.

A Phase 1 dose escalating study of double mutant heat-labile toxin LTR192G/L211A (dmLT) from Enterotoxigenic Escherichia coli (ETEC) by sublingual or oral immunization. Bernstein, DI; Pasetti, MF; Brady, R; Buskirk, AD; Wahid, R; Dickey, M; Cohen, M; Baughman, H; El-Khorazaty, J; Maier, N; et al. Vaccine. 2019; 37:602-611.

Randomized trial comparing the safety and antibody responses to live attenuated versus inactivated influenza vaccine when administered to breastfeeding women. Brady, RC; Jackson, LA; Frey, SE; Shane, AL; Walter, EB; Swamy, GK; Schlaudecker, EP; Szefer, E; Wolff, M; McNeal, MM; et al. Vaccine. 2018; 36:4663-4671.

Randomized clinical trial of a single versus a double dose of 13-valent pneumococcal conjugate vaccine in adults 55 through 74 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine. Jackson, LA; El Sahly, HM; George, S; Winokur, P; Edwards, K; Brady, RC; Rouphael, N; Keitel, WA; Mulligan, MJ; Burton, RL; et al. Vaccine. 2018; 36:606-614.

Improving a process to obtain hepatitis B serology among patients treated with infliximab at a large urban children's hospital. Jean, MR; Weaver, A; Mastin-Diebold, T; Kissinger, K; Smitherman, EA; Favier, L; Danziger-Isakov, L; Williams, E; Brady, RC; Huggins, J; et al. BMJ Open Quality. 2017; 6:e000092-e000092.

Priming Vaccination With Influenza Virus H5 Hemagglutinin Antigen Significantly Increases the Duration of T cell Responses Induced by a Heterologous H5 Booster Vaccination. Hoft, DF; Lottenbach, K; Goll, JB; Hill, H; Winokur, PL; Patel, SM; Brady, RC; Chen, WH; Edwards, K; Creech, CB; et al. Journal of Infectious Diseases. 2016; 214:1020-1029.

Adolescent Vaccination Strategies: Interventions to Increase Coverage. Lehmann, CE; Brady, RC; Battley, RO; Huggins, JL. Pediatric Drugs. 2016; 18:273-285.

Demographics of hepatitis C in Southwest Ohio (2010 to 2015). Woltmann, J; Burke, P; Brady, R; Blackard, JT. Hepatitis Monthly. 2016; 16.

Single-dose Live Oral Cholera Vaccine CVD 103-HgR Protects Against Human Experimental Infection With Vibrio cholerae O1 El Tor. Chen, WH; Cohen, MB; Kirkpatrick, BD; Brady, RC; Galloway, D; Gurwith, M; Hall, RH; Kessler, RA; Lock, M; Haney, D; et al. Clinical Infectious Diseases. 2016; 62:1329-1335.

Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine. Mbawuike, IN; Atmar, RL; Patel, SM; Corry, DB; Winokur, PL; Brady, RC; Chen, WH; Edwards, KM; Creech, CB; Jr, WE B; et al. Vaccine. 2016; 34:547-554.